BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 12143050)

  • 1. Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis.
    Nguyen MH; Garcia RT; Simpson PW; Wright TL; Keeffe EB
    Hepatology; 2002 Aug; 36(2):410-7. PubMed ID: 12143050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
    Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
    Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis.
    Gopal P; Yopp AC; Waljee AK; Chiang J; Nehra M; Kandunoori P; Singal AG
    Clin Gastroenterol Hepatol; 2014 May; 12(5):870-7. PubMed ID: 24095974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
    World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass.
    Chan SL; Mo F; Johnson PJ; Siu DY; Chan MH; Lau WY; Lai PB; Lam CW; Yeo W; Yu SC
    HPB (Oxford); 2014 Apr; 16(4):366-72. PubMed ID: 23980880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.
    El-Serag HB; Kanwal F; Davila JA; Kramer J; Richardson P
    Gastroenterology; 2014 May; 146(5):1249-55.e1. PubMed ID: 24462733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma and its early detection by AFP testing in Mongolia.
    Oyunsuren T; Sanduijav R; Davaadorj D; Nansalmaa D
    Asian Pac J Cancer Prev; 2006; 7(3):460-2. PubMed ID: 17059345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum interleukin-10 and alpha-fetoprotein: A combined diagnostic approach for hepatocellular carcinoma in Egyptians with HCV.
    Sharafeldin MA; Suef RA; Mousa AA; Ziadah DH; Farag MMS
    Pathol Res Pract; 2024 Jun; 258():155327. PubMed ID: 38692084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study.
    Liu D; Luo Y; Chen L; Chen L; Zuo D; Li Y; Zhang X; Wu J; Xi Q; Li G; Qi L; Yue X; Zhang X; Sun Z; Zhang N; Song T; Lu W; Guo H
    Cancer Biol Med; 2021 Feb; 18(1):256-270. PubMed ID: 33628599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
    Peng YC; Chan CS; Chen GH
    Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
    Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of SCCA-IgM as a biomarker of liver disease in an Asian cohort of patients.
    Bui Huu H; Ha Thuc N; Thi Le HP; Thi Thanh TD; Luong Bac A; Tiribelli C; Pontisso P; Gallotta A; Paneghetti L; Fassina G
    Scand J Clin Lab Invest; 2018 May; 78(3):204-210. PubMed ID: 29381084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
    Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
    Yao M; Zhao J; Lu F
    Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
    Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
    World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum midkine is a more sensitive predictor for hepatocellular carcinoma than Dickkopf-1 and alpha-L-fucosidase in cirrhotic HCV patients.
    El-Shayeb AF; El-Habachi NM; Mansour AR; Zaghloul MS
    Medicine (Baltimore); 2021 Apr; 100(17):e25112. PubMed ID: 33907088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer.
    Wan L; Guo L; Hu Y; Huang H; Zhang M; Xu K; De G; Zheng F; Wu Z; Hu C; Wen Z
    Clin Biochem; 2021 Mar; 89():44-50. PubMed ID: 33309517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.